BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6338139)

  • 1. Expression of procoagulant activity in a human monocyte-like cell line.
    Ewan VA; Edwards RL; Rickles FR
    J Lab Clin Med; 1983 Mar; 101(3):401-10. PubMed ID: 6338139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of monocyte-macrophage procoagulant activity by transformed cell lines.
    Rambaldi A; Alessio G; Casali B; Passerini CG; Donati MB; Mantovani A; Semeraro N
    J Immunol; 1986 May; 136(10):3848-55. PubMed ID: 3701063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage procoagulants.
    Edwards RL; Rickles FR
    Prog Hemost Thromb; 1984; 7():183-209. PubMed ID: 6397766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A distinct "slow" cellular pathway involving soluble mediators for the T cell-instructed induction of monocyte tissue factor activity in an allogeneic immune response.
    Helin H; Edgington TS
    J Immunol; 1984 May; 132(5):2457-63. PubMed ID: 6232319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tacrolimus hydrate (FK-506) on the expression of tissue factor in THP-1 human monocyte cell line.
    Zaman AK
    Hokkaido Igaku Zasshi; 2000 May; 75(3):179-86. PubMed ID: 10884973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant expression of tissue factor antigen and procoagulant activity on human monocytes activated with LPS and low dose cycloheximide.
    Walsh JD; Geczy CL
    Thromb Haemost; 1991 Nov; 66(5):552-8. PubMed ID: 1803619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of a monoclonal antibody (A1-3) that binds selectively to activated monocytes and inhibits monocyte procoagulant activity.
    Ewan VA; Cieplinski W; Hancock WW; Goldschneider I; Boyd AW; Rickles FR
    J Immunol; 1986 Apr; 136(7):2408-15. PubMed ID: 3950416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tissue factor procoagulant activity on the surface of feline leukocytes in response to treatment with lipopolysaccharide and heat-inactivated fetal bovine serum.
    Stokol T; Daddona JL; Choi B
    Am J Vet Res; 2010 Jun; 71(6):623-9. PubMed ID: 20513176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of monocyte procoagulant activity with OKT3 antibody.
    Iitaka M; Iwatani Y; Row VV; Volpé R
    J Immunol; 1987 Sep; 139(5):1617-23. PubMed ID: 3114371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte procoagulant activity induced by adherence to an artificial surface is reduced by end-point immobilized heparin-coating of the surface.
    Barstad RM; Hamers MJ; Møller AS; Sakariassen KS
    Thromb Haemost; 1998 Feb; 79(2):302-5. PubMed ID: 9493580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
    Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
    Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tissue factor on monocytes by adhesion to endothelial cells.
    Lo SK; Cheung A; Zheng Q; Silverstein RL
    J Immunol; 1995 May; 154(9):4768-77. PubMed ID: 7536780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of monocyte procoagulant activity by adherence to different surfaces.
    van Ginkel CJ; van Aken WG; Oh JI; Vreeken J
    Br J Haematol; 1977 Sep; 37(1):35-45. PubMed ID: 588477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13.
    Osnes LT; Westvik AB; Joø GB; Okkenhaug C; Kierulf P
    Cytokine; 1996 Nov; 8(11):822-7. PubMed ID: 9047078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal peptidoglycan initiates an inflammatory response and procoagulant activity in human vascular endothelial cells: a comparison with highly purified lipoteichoic acid and TSST-1.
    Mattsson E; Heying R; van de Gevel JS; Hartung T; Beekhuizen H
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):110-7. PubMed ID: 18031538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mononuclear cell modulation of fibroblast procoagulant activity.
    Korn JH; Rickles FR; Ewan VA; Edwards RL; Myers TJ; Onder O
    J Lab Clin Med; 1982 May; 99(5):657-68. PubMed ID: 6950992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis.
    Henriksson CE; Klingenberg O; Ovstebø R; Joø GB; Westvik AB; Kierulf P
    Thromb Haemost; 2005 Dec; 94(6):1236-44. PubMed ID: 16411400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor expression during monocyte-macrophage differentiation.
    van den Eijnden MM; Steenhauer SI; Reitsma PH; Bertina RM
    Thromb Haemost; 1997 Jun; 77(6):1129-36. PubMed ID: 9241745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane environment rather than tissue factor expression determines thrombin formation triggered by monocytic cells undergoing apoptosis.
    Stampfuss JJ; Censarek P; Bein D; Schrör K; Grandoch M; Naber C; Weber AA
    J Leukoc Biol; 2008 Jun; 83(6):1379-81. PubMed ID: 18305177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.